The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prediction of Medium-Term Outcome by Cortisol Response to the Combined Dexamethasone-CRH Test in Patients With Remitted Depression
Abstract
OBJECTIVE: Current hypotheses hold that mechanisms underlying abnormal hypothalamic-pituitary-adrenocortical (HPA) function are causal factors in the precipitation of depression. If this is the case, then normalization of initially disturbed HPA regulation should indicate a good prognosis and persistent HPA dysregulation should be associated with a greater likelihood of relapse or chronicity. METHOD: The combined dexamethasone/corticotropin-releasing hormone test was administered twice to inpatients with major depression (N = 40), once after initiation of treatment and once after remission, shortly before discharge. RESULTS: Patients with a high cortisol response on both occasions or with a substantially increased cortisol response at discharge were at much higher risk for relapse within the next 6 months than those with low cortisol responses. CONCLUSIONS: An easy-to-administer neuroendocrine test allows the prediction of medium-term outcome in patients with remitted depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Self-citation
Cited by
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Self-citationDiscovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Biological and psychological markers of stress in humans: Focus on the Trier Social Stress Test
Allen, A. P., Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.005 · Cited by 734
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
Self-citationStress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy
Holsboer, F. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00352-9 · Cited by 575
Self-citationStress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
“…depression, as normalization of subsequent test results predicts beneficial clinical outcome (Appelhof et al. 2006; Binder et al. 2009; Hatzinger et al. 2002; Hennings et al. 2009; Heuser et al. 1994; Holsboer-Trachsler et al. 1991; Ising et al. 2005, 2007a; Schüle et al. 2009; Zobel et al. 1999).”
BackgroundSelf-citationProspective biomarkers of major depressive disorder: A systematic review and meta-analysis
Kennis, M., Gerritsen, L., van Dalen, M., Williams, A., Cuijpers, P., & Bockting, C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0585-z · Cited by 435
Ridder, S., Chourbaji, S., Hellweg, R., Urani, A., Zacher, C., Schmid, W., Zink, M., Hörtnagl, H., Flor, H., Henn, F. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0736-05.2005 · Cited by 382
“Clinical studies have demonstrated a hyperactivity of the hypothalamic–pituitary–adrenal (HPA) system with elevated plasma cortisol levels in the majority of patients with major depression (Holsboer and Barden , 1996; Zobel et al., 1999; Holsboer, 2000).”
Backgroundvan Praag, H. M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.031 · Cited by 377
Lymphocytes as a neural probe: potential for studying psychiatric disorders
Gladkevich, A., Kauffman, H. F., & Korf, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.009 · Cited by 360
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Self-citationIsing, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341
Self-citationVan Reeth, O., Weibel, L., Spiegel, K., Leproult, R., Dugovic, C., & Maccari, S. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0097 · Cited by 293
Touma, C., Gassen, N. C., Herrmann, L., Cheung-Flynn, J., Büll, D. R., Ionescu, I. A., Heinzmann, J.-M., Knapman, A., Siebertz, A., Depping, A.-M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.023 · Cited by 273
Self-citationKunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
The glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192
The cortisol awakening response and major depression: examining the evidence
Dedovic, K., & Ngiam, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62289 · Cited by 191
The brain mineralocorticoid receptor and stress resilience
ter Heegde, F., De Rijk, R. H., & Vinkers, C. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.022 · Cited by 187
Neuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Appelhof, B. C., Huyser, J., Verweij, M., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Tijssen, J. G. P., Wiersinga, W. M., & Schene, A. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.008 · Cited by 154
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152
Self-citationGlucocorticoid Receptor Function In Vitro in Patients with Major Depression
Pariante, C. M. (2004) · Stress · doi:10.1080/10253890500069650 · Cited by 147
Reppermund, S., Zihl, J., Lucae, S., Horstmann, S., Kloiber, S., Holsboer, F., & Ising, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.027 · Cited by 147
Self-citationBiomarkers of depression in cancer patients
Jehn, C. F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A. C., Schmid, P., Possinger, K., & Flath, B. C. (2006) · Cancer · doi:10.1002/cncr.22294 · Cited by 139
Kudielka, B. M., Schmidt-Reinwald, A. K., Hellhammer, D. H., & Kirschbaum, C. (1999) · Neuroendocrinology · doi:10.1159/000054504 · Cited by 135
Salivary cortisol levels and the 2-year course of depressive and anxiety disorders
Vreeburg, S. A., Hoogendijk, W. J. G., DeRijk, R. H., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.017 · Cited by 121
“…responses to the Dex/CRH test or DST predict relapse in remitted outpatients with depressive disorder (Ribeiro et al., 1993; Appelhof et al., 2006; Aubry et al., 2007; Pintor et al., 2009), panic disorder (Coryell et al., 1989), or in depressed inpatients (Zobel et al., 1999; Ising et al., 2007).”
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity
Laryea, G., Schütz, G., & Muglia, L. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1187 · Cited by 106
The impact of treatment on HPA axis activity in unipolar major depression
McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103
Morris, M. C., Rao, U., & Garber, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.059 · Cited by 102
“Several converging lines of evidence suggest that persistent HPA alterations during remission are associated with increased risk for recurrence (Appelhof et al., 2006; Chopra et al., 2008; Zobel et al., 1999).”
BackgroundCONNAN, F., LIGHTMAN, S., LANDAU, S., WHEELER, M., TREASURE, J., & CAMPBELL, I. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.12.005 · Cited by 80
Zobel, A. W., Schulze-Rauschenbach, S., von Widdern, O. C., Metten, M., Freymann, N., Grasmäder, K., Pfeiffer, U., Schnell, S., Wagner, M., & Maier, W. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.12.002 · Cited by 75
“(3) HPA overdrive might continue despite of clinical remission; this constellation indicates a higher risk for relapse within six months (Zobel et al., 1999; Zobel et al., 2000).”
BackgroundSelf-citationLeistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Hardeveld, F., Spijker, J., Vreeburg, S. A., Graaf, R. D., Hendriks, S. M., Licht, C. M. M., Nolen, W. A., Penninx, B. W. J. H., & Beekman, A. T. F. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.027 · Cited by 58
Bockting, C. L. H., Lok, A., Visser, I., Assies, J., Koeter, M. W., & Schene, A. H. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.044 · Cited by 57
Howell, M. P., & Muglia, L. J. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.05.001 · Cited by 46
Aydin, A., Selvi, Y., Besiroglu, L., Boysan, M., Atli, A., Ozdemir, O., Kilic, S., & Balaharoglu, R. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.007 · Cited by 40
Heiske, A., Jesberg, J., Krieg, J.-C., & Vedder, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300056 · Cited by 35
Krieg, J.-C., Lauer, C. J., Schreiber, W., Modell, S., & Holsboer, F. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00348-7 · Cited by 32
Self-citationThe hypothalamo–pituitary–adrenal axis in major affective disorder: a review
Christensen, M. V., & Kessing, L. V. (2001) · Nordic Journal of Psychiatry · doi:10.1080/080394801317080873 · Cited by 25
“These early results were later con rmed (26, 30)— most recently in a study published in 1999 involving 42 inpatients with major depression (31).”
BackgroundHennings, J. M., Ising, M., Uhr, M., Holsboer, F., & Lucae, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.937582 · Cited by 13
Self-citation
Metadata
- Authors
- Zobel, A. W., Yassouridis, A., Frieboes, R.-M., & Holsboer, F.
- Venue
- American Journal of Psychiatry
- Published
- 1999-06-01
- Volume
- 156
- Issue
- 6
- Pages
- 949-951
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2114298072
- Cited by
- 229
- References
- 1
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.